riluzole has been researched along with Sleep Apnea Syndromes in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Radulovacki, M | 1 |
| Pavlovic, S | 1 |
| Rakic, A | 1 |
| Janelidze, M | 1 |
| Shermulis, L | 1 |
| Carley, DW | 1 |
1 other study available for riluzole and Sleep Apnea Syndromes
| Article | Year |
|---|---|
Riluzole suppresses post-sigh, but not spontaneous apnoeas during sleep in rats.
Topics: Animals; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Rats; Rats, Spra | 2001 |